Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase (original) (raw)

References

  1. Curci, J.A., Lee, J.K. & Thompson, R.W. Pathogenesis of Abdominal Aortic Aneurysm. in Current Therapy in Vascular Surgery (eds. Ernst, C.B. & Stanley, J.C.) 199–206 (Elsevier, Philadelphia, 2001).
    Google Scholar
  2. Upchurch, G.R., Jr. Gene therapy to treat aortic aneurysms: right goal, wrong strategy. Circulation 112, 939–940 (2005).
    Article Google Scholar
  3. Pyo, R. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105, 1641–1649 (2000).
    Article CAS Google Scholar
  4. Longo, G.M. et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110, 625–632 (2002).
    Article CAS Google Scholar
  5. Allaire, E., Forough, R., Clowes, M., Starcher, B. & Clowes, A.W. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J. Clin. Invest. 102, 1413–1420 (1998).
    Article CAS Google Scholar
  6. Krettek, A., Sukhova, G.K. & Libby, P. Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis. Arterioscler. Thromb. Vasc. Biol. 23, 582–587 (2003).
    Article CAS Google Scholar
  7. Huffman, M.D. et al. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128, 429–438 (2000).
    Article CAS Google Scholar
  8. Rowe, D., McGoodwin, E., Martin, G. & Grahn, D. Decreased lysyl oxidase activity in the aneurysm-prone, mottled mouse. J. Biol. Chem. 252, 939–942 (1977).
    CAS PubMed Google Scholar
  9. Bode, M.K. et al. Increased amount of type III pN-collagen in AAA when compared with AOD. Eur. J. Vasc. Endovasc. Surg. 23, 413–420 (2002).
    Article CAS Google Scholar
  10. Bigatel, D.A. et al. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J. Vasc. Surg. 29, 130–138 (1999).
    Article CAS Google Scholar
  11. Petrinec, D. et al. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg. 23, 336–346 (1996).
    Article CAS Google Scholar
  12. Prall, A.K. et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J. Vasc. Surg. 35, 923–929 (2002).
    Article Google Scholar
  13. Mosorin, M. et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J. Vasc. Surg. 34, 606–610 (2001).
    Article CAS Google Scholar
  14. Baxter, B.T. et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J. Vasc. Surg. 36, 1–12 (2002).
    Article Google Scholar
  15. Allaire, E. et al. Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann. Surg. 239, 417–427 (2004).
    Article Google Scholar
  16. Buth, J. & Harris, P. Endovascular Treatment of Aortic Aneurysms. in Vascular Surgery (ed. Rutherford, R.B.) 1452–1475 (Elsevier, Philadelphia, 2005).
    Google Scholar
  17. Patel, M.I., Melrose, J., Ghosh, P. & Appleberg, M. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J. Vasc. Surg. 24, 82–92 (1996).
    Article CAS Google Scholar
  18. Manning, A.M. & Davis, R.J. Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2, 554–565 (2003).
    Article CAS Google Scholar
  19. Galis, Z.S. & Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90, 251–262 (2002).
    Article CAS Google Scholar
  20. Mietus-Snyder, M., Glass, C.K. & Pitas, R.E. Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBPbeta. Arterioscler. Thromb. Vasc. Biol. 18, 1440–1449 (1998).
    Article CAS Google Scholar
  21. Yan, L., Borregaard, N., Kjeldsen, L. & Moses, M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258–37265 (2001).
    Article CAS Google Scholar
  22. Maki, J. et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106, 2503–2509 (2002).
    Article Google Scholar
  23. Ricci, R. et al. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 306, 1558–1561 (2004).
    Article CAS Google Scholar
  24. Bagowski, C.P. & Ferrell, J.E., Jr. Bistability in the JNK cascade. Curr. Biol. 11, 1176–1182 (2001).
    Article CAS Google Scholar
  25. Borsello, T. et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9, 1180–1186 (2003).
    Article CAS Google Scholar
  26. Daugherty, A., Manning, M.W. & Cassis, L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105, 1605–1612 (2000).
    Article CAS Google Scholar
  27. Shin, M. et al. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim. Biophys. Acta 1589, 311–316 (2002).
    Article CAS Google Scholar
  28. Gum, R., Wang, H., Lengyel, E., Juarez, J. & Boyd, D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481–1493 (1997).
    Article CAS Google Scholar
  29. Cho, A., Graves, J. & Reidy, M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20, 2527–2532 (2000).
    Article CAS Google Scholar
  30. Ventura, J.J., Kennedy, N.J., Flavell, R.A. & Davis, R.J. JNK regulates autocrine expression of TGF-beta1. Mol. Cell 15, 269–278 (2004).
    Article CAS Google Scholar
  31. Leask, A., Holmes, A., Black, C.M. & Abraham, D.J. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J. Biol. Chem. 278, 13008–13015 (2003).
    Article CAS Google Scholar
  32. Schlumberger, W., Thie, M., Rauterberg, J. & Robenek, H. Collagen synthesis in cultured aortic smooth muscle cells. Modulation by collagen lattice culture, transforming growth factor-beta 1, and epidermal growth factor. Arterioscler. Thromb. 11, 1660–1666 (1991).
    Article CAS Google Scholar
  33. Dai, J. et al. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation 112, 1008–1015 (2005).
    Article CAS Google Scholar
  34. Takagi, Y., Ishikawa, M., Nozaki, K., Yoshimura, S. & Hashimoto, N. Increased expression of phosphorylated c-Jun amino-terminal kinase and phosphorylated c-Jun in human cerebral aneurysms. Neurosurgery 51, 997–1002 (2002).
    PubMed Google Scholar
  35. Parodi, F.E., Mao, D., Ennis, T.L., Bartoli, M.A. & Thompson, R.W. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB. J. Vasc. Surg. 41, 479–489 (2005).
    Article Google Scholar
  36. Nakashima, H. et al. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors. Circulation 109, 132–138 (2004).
    Article CAS Google Scholar
  37. Kim, H.S., Luo, L., Pflugfelder, S.C. & Li, D.Q. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 46, 840–848 (2005).
    Article Google Scholar
  38. Sato, H. & Seiki, M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395–405 (1993).
    CAS PubMed Google Scholar
  39. Papa, S., Zazzeroni, F., Pham, C.G., Bubici, C. & Franzoso, G. Linking JNK signaling to NF-kappaB: a key to survival. J. Cell Sci. 117, 5197–5208 (2004).
    Article CAS Google Scholar
  40. Bennett, B.L. et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98, 13681–13686 (2001).
    Article CAS Google Scholar
  41. Adachi, M. et al. Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells. FEBS Lett. 554, 77–80 (2003).
    Article CAS Google Scholar
  42. Aoki, H. et al. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J. Biol. Chem. 277, 10244–10250 (2002).
    Article CAS Google Scholar
  43. Zempo, N. et al. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg. 20, 209–217 (1994).
    Article CAS Google Scholar
  44. Palamakumbura, A.H. & Trackman, P.C. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal. Biochem. 300, 245–251 (2002).
    Article CAS Google Scholar

Download references